Literature DB >> 26522395

Pitfalls and Limitations of PET/CT in Brain Imaging.

Eric Salmon1, Claire Bernard Ir1, Roland Hustinx2.   

Abstract

Neurologic applications were at the forefront of PET imaging when the technique was developed in the mid-1970s. Although oncologic indications have become prominent in terms of number of studies performed worldwide, neurology remains a major field in which functional imaging provides unique information, both for clinical and research purposes. The evaluation of glucose metabolism using FDG remains the most frequent exploration, but in recent years, alternative radiotracers have been developed, including fluorinated amino acid analogues for primary brain tumor imaging and fluorinated compounds for assessing the amyloid deposits in patients with suspected Alzheimer disease. As the brain is enclosed in the skull, which presents fixed landmarks, it is relatively easy to coregister images obtained with various cross-sectional imaging methods, either functional or anatomical, with a relatively high accuracy and robustness. Nevertheless, PET in neurology has fully benefited from the advent of hybrid imaging. Attenuation and scatter correction is now much faster and equally accurate, using CT as compared with the traditional transmission scan using an external radioactive source. The perfect coregistration with the CT data, which is now systematically performed, also provides its own set of valuable information, for instance regarding cerebral atrophy. However, hybrid imaging in neurology comes with pitfalls and limitations, in addition to those that are well known, for example, blood glucose levels or psychotropic drugs that greatly affect the physiological FDG uptake. Movements of the patient's head, either during the PET acquisition or between the PET and the CT acquisitions will generate artifacts that may be very subtle yet lead to erroneous interpretation of the study. Similarly, quantitative analysis, such as voxel-based analyses, may prove very helpful in improving the diagnostic accuracy and the reproducibility of the reading, but a wide variety of artifacts may also be introduced, and should therefore be identified and corrected.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26522395     DOI: 10.1053/j.semnuclmed.2015.03.008

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.446


  15 in total

1.  Preclinical Development and First-in-Human Imaging of the Integrin αvβ6 with [18F]αvβ6-Binding Peptide in Metastatic Carcinoma.

Authors:  Sven H Hausner; Richard J Bold; Lina Y Cheuy; Helen K Chew; Megan E Daly; Ryan A Davis; Cameron C Foster; Edward J Kim; Julie L Sutcliffe
Journal:  Clin Cancer Res       Date:  2018-11-06       Impact factor: 12.531

2.  Distinctive FDG-PET/CT Findings in Acute Neurological Hospital Care.

Authors:  Josef G Heckmann; Wolfgang Niedermeier; Markus Büchner; Bernhard Scher
Journal:  Neurohospitalist       Date:  2018-10-15

3.  Novel window for cancer nanotheranostics: non-invasive ocular assessments of tumor growth and nanotherapeutic treatment efficacy in vivo.

Authors:  Mayank Goswami; Xinlei Wang; Pengfei Zhang; Wenwu Xiao; Sarah J Karlen; Yuanpei Li; Robert J Zawadzki; Marie E Burns; Kit S Lam; Edward N Pugh
Journal:  Biomed Opt Express       Date:  2018-12-11       Impact factor: 3.732

4.  Super-Resolution PET Imaging Using Convolutional Neural Networks.

Authors:  Tzu-An Song; Samadrita Roy Chowdhury; Fan Yang; Joyita Dutta
Journal:  IEEE Trans Comput Imaging       Date:  2020-01-06

5.  Noise2Void: unsupervised denoising of PET images.

Authors:  Tzu-An Song; Fan Yang; Joyita Dutta
Journal:  Phys Med Biol       Date:  2021-11-01       Impact factor: 3.609

6.  Dynamic 13 C MR spectroscopy as an alternative to imaging for assessing cerebral metabolism using hyperpolarized pyruvate in humans.

Authors:  Junjie Ma; Marco C Pinho; Crystal E Harrison; Jun Chen; Chenhao Sun; Edward P Hackett; Jeff Liticker; James Ratnakar; Galen D Reed; Albert P Chen; A Dean Sherry; Craig R Malloy; Steven M Wright; Christopher J Madden; Jae Mo Park
Journal:  Magn Reson Med       Date:  2021-10-22       Impact factor: 4.668

7.  Clinical Translation of a 68Ga-Labeled Integrin αvβ6-Targeting Cyclic Radiotracer for PET Imaging of Pancreatic Cancer.

Authors:  Xun Feng; Yanpu Wang; Dehua Lu; Xiaoxia Xu; Xin Zhou; Huiyuan Zhang; Ting Zhang; Hua Zhu; Zhi Yang; Fan Wang; Nan Li; Zhaofei Liu
Journal:  J Nucl Med       Date:  2020-02-21       Impact factor: 10.057

Review 8.  Positron Emission Tomography After Ischemic Brain Injury: Current Challenges and Future Developments.

Authors:  Zhuoran Wang; Conrad Mascarenhas; Xiaofeng Jia
Journal:  Transl Stroke Res       Date:  2020-01-14       Impact factor: 6.829

9.  PET Use in Cancer Diagnosis, Treatment, and Prognosis.

Authors:  Naresh Damuka; Meghana Dodda; Kiran Kumar Solingapuram Sai
Journal:  Methods Mol Biol       Date:  2022

Review 10.  Brain Vascular Imaging Techniques.

Authors:  Bàrbara Laviña
Journal:  Int J Mol Sci       Date:  2016-12-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.